Omada Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Omada Health, Inc. (OMDA), an emerging growth company, filed this Current Report on Form 8-K on January 12, 2026. The filing was made in advance of a presentation at the 44th Annual J.P. Morgan Healthcare Conference to announce preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) containing these preliminary unaudited figures, but the data itself is not included in the provided text.
Material Changes
No specific material changes versus prior periods are detailed in the filing text. The document serves as a notification that preliminary results for the 2025 fiscal year have been issued and are subject to final closing procedures and annual independent audit.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the preliminary results. The filing explicitly states that the unaudited results are preliminary and subject to adjustment. No specific forward-looking guidance, risk factors, or contingencies are detailed within the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific preliminary revenue and financial figures for Q4 and FY 2025.
- Monitor the upcoming public webcast at the J.P. Morgan Healthcare Conference for management commentary and detailed outlook.
- Verify the final audited results in the subsequent Form 10-K filing, as the current figures are unaudited and subject to adjustment.
- Confirm the company's status as an emerging growth company and any related accounting standard elections.